Sumitomo Dainippon Pharma Co., Ltd.

Japan

  • 1m
  • 3m
  • 6m
  • 1y
  • 2y
  • 5y
Apr 28, 2017
Prev close: 1,828
Apr 28, 2017
Market cap:
Market cap(USD):
727,361.43M
6,522.83M
Shares: 397.90M

Currency in JPY

Company profile

Market(Ticker): TKS(4506)
Sector:
Industry:
Health Technology
Pharmaceuticals: Other
Full time employees: 6,697

Business summary

Sumitomo Dainippon Pharma Co., Ltd. engages in the manufacture, sale, import, and export of pharmaceuticals products. It operates through the Pharmaceutical Business and Other Business segments. The Pharmaceutical Business segment handles the creation of new pharmaceutical products. The Other Business segment division includes food ingredients and additives, chemical products materials, veterinary drugs, and diagnostics. The company was founded on May 14, 1897 and is headquartered in Osaka, Japan.

In the news

Financial highlights

Mar 2016

  • Local currency
  • US Dollar
Revenue 403,206M
Gross profit 293,016M
Operating income 36,929M
Income before tax 39,560M
Net income 24,697M
EBITDA 57,194M
Diluted EPS 62.16
Dividends per share 18
Total assets 707,715M
Total liabilities 261,243M
Total equity 446,472M
Operating cash flow 52,486M

Currency in JPY

Revenue 3,357.69M
Gross profit 2,440.08M
Operating income 307.52M
Income before tax 329.43M
Net income 205.66M
EBITDA 476.28M
Diluted EPS 0.51
Dividends per share 0.14
Total assets 6,296.67M
Total liabilities 2,324.32M
Total equity 3,972.34M
Operating cash flow 437.07M

Currency in USD

Valuation measures

Mar 2016

PER 20.84
ROA 3.48%
ROE 5.50%
Operating margin 9.15%
Profit margin 6.12%

Key executive

  • President, CEO & Representative Director: Masayo Tada
  • General Manager-Research Technology: Yoshiharu Ikeda
  • Director, Executive Officer & Head-Regenerative: Toru Kimura
  • Executive Officer: Chiang J. Li
  • Executive Officer: Antony Loebel

Share holders

  • Sumitomo Chemical Co., Ltd.(50.1%)
  • Inabata & Co., Ltd.(6.8%)
  • Nomura Asset Management Co., Ltd.(2.6%)
  • Nippon Life Insurance Co.(1.9%)
  • Sumitomo Mitsui Banking Pension Fund(1.7%)
  • Nikko Asset Management Co., Ltd.(1.5%)
  • Sumitomo Life Insurance Co.(1.4%)
  • MS&AD Insurance Group Holdings, Inc.(1.4%)
  • Daiwa Asset Management Co. Ltd.(1.3%)
  • Sumitomo Dainippon Pharma Employee Stock Ownership Plan(1.0%)

Address

  • Website: http://www.ds-pharma.co.jp
  • Address: 2-6-8 Dosho-machi, Chuo-Ku, Osaka, 541-0045, Japan
  • Phone: +81.6.6203.5321

Copyright © 2017 FactSet Research Systems Inc. All rights reserved.